The data about “Depuralina” — a new combined herbal agent with the active probiotic ingredients are given in the article. Problems of pharmacodynamics of some components are highlighted. The perspectives of the “Depuralina” clinical usage as a potential drug for correction of disturbances in metabolic syndrome are pathogenically explained.
